As of April 2024 Anixa Biosciences has a market cap of $95.06 Million. This makes Anixa Biosciences the world's 7423th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $95.06 M | -21.14% |
2023 | $0.12 B | -7.49% |
2022 | $0.13 B | 46.01% |
2021 | $89.25 M | 22.21% |
2020 | $73.03 M | 9.51% |
2019 | $66.68 M | -10.49% |
2018 | $74.5 M | 90.1% |
2017 | $39.19 M | -17.08% |
2016 | $47.26 M | 79.97% |
2015 | $26.26 M | 8.67% |
2014 | $24.16 M | -39.22% |
2013 | $39.76 M | 19.42% |
2012 | $33.29 M | 71.86% |
2011 | $19.37 M | -39.99% |
2010 | $32.28 M | -65.1% |
2009 | $92.52 M |
On Apr 24th, 2024 the market cap of Anixa Biosciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.51 B | 443.62% | ๐บ๐ธ USA |